The effect of TSUBU-TSUBU therapy for chronic neuropathic pain

JRCT ID: jRCT1062200005

Registered date:15/06/2020

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: Post Herpetic Neuralgia, Post Operative Chest Pain, and Neuropathic pain
• Date of first enrollment: 30/11/2020
• Target sample size: 26
• Study type: Interventional
• Intervention(s): The change of pain scale (VAS values) are investigated after the painfull region are coverd with therapy sheets ot plasebo sheets.

Outcome(s)

• Primary Outcome: VAS values
• Secondary Outcome: PainDETECT, Pain VIsion, PDAS, AIS, Sleeping durations, other therapy such as neural block, and the usage of common and rescue medicine

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: < 90age old
• Gender: Both
• Include criteria: Patients who meet all of the following; 1) Age >= 20 and < 90, 2) Patients who have Post Herpetic Neuralgia, Post Operative Chest Pain, and other Neuropathic pain with VAS values >= 50 despite of general treatments, 3) Painfull skin region can be all coverd with therapy sheets or plasebo sheets, 4) Patients who are able to obtain own consent by themselves after enough explanations and understandings.
• Exclude criteria: Patients who meet at least one of the following; 1) Pregnant and possibly pregnant women, 2) Patient who have the skin disease, 3) Patient who the investigator judged to be inappropriate for this research.

Related Information

• Primary Sponsor: Arakawa Kyosuke